Literature DB >> 16680584

Neuropsychiatric and cognitive changes after surgery for primary hyperparathyroidism.

Cornelia M E Dotzenrath1, Ana Karena Kaetsch, Henrich Pfingsten, Kenko Cupisti, Norbert Weyerbrock, Alexander Vossough, Pablo E Verde, Christian Ohmann.   

Abstract

INTRODUCTION: Neuropsychiatric symptoms and cognitive impairment are mental manifestations of primary hyperparathyroidism (pHPT). The aim of our study was to determine if surgical treatment results in a long-lasting full recovery from these symptoms.
METHODS: In a prospective case-control study with matching pairs, mental changes were examined preoperatively and 6 months postoperatively in 30 patients with primary hyperparathyroidism and 30 patients with nontoxic nodular goiter using the Hamilton depression score and four cognitive tests: DEM Tect, MWT (multiple word test), ZVT, and Benton test.
RESULTS: Patients with pHPT demonstrated significantly more cognitive changes (P < 0.0001) with significant improvement 6 months postoperatively (P < 0.0001). Patients with pHPT presented more psychopathologic symptoms than patients of the control group (P = NS), and there was a tendency towards recovery in the pHPT group postoperatively. There was no correlation between biochemistry and psychopathologic or cognitive changes in the pHPT group.
CONCLUSIONS: Patients with pHPT often present with neuropsychiatric symptoms and cognitive impairment. A successful parathyroid operation improves cognitive disorders in particular.

Entities:  

Mesh:

Year:  2006        PMID: 16680584     DOI: 10.1007/s00268-005-0444-8

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  16 in total

1.  New onset of neuropsychiatric symptoms in the elderly: possible primary hyperparathyroidism.

Authors:  Lea C Watson; Christine E Marx
Journal:  Psychosomatics       Date:  2002 Sep-Oct       Impact factor: 2.386

Review 2.  Incidence, type and severity of psychic symptoms in patients with sporadic primary hyperparathyroidism.

Authors:  J Rastad; C Joborn; G Akerström; S Ljunghall
Journal:  J Endocrinol Invest       Date:  1992       Impact factor: 4.256

Review 3.  Primary hyperparathyroidism and neuropsychiatric alterations in a nonagenarian woman.

Authors:  Camilla Prete; Luca Foppiani; Stefano Trasciatti; Barbara Senesi; Massimo Veneziano; Antonella Barone; Ernesto Palummeri
Journal:  Aging Clin Exp Res       Date:  2005-02       Impact factor: 3.636

4.  Patient-based surgical outcome tool demonstrating alleviation of symptoms following parathyroidectomy in patients with primary hyperparathyroidism.

Authors:  Janice L Pasieka; Louise L Parsons; Michael J Demeure; Stuart Wilson; Peter Malycha; Jean Jones; Beth Krzywda
Journal:  World J Surg       Date:  2002-05-21       Impact factor: 3.352

5.  Neuropsychiatric manifestations in patients of primary hyperparathyroidism and outcome following surgery.

Authors:  A Goyal; S Chumber; N Tandon; R Lal; A Srivastava; S Gupta
Journal:  Indian J Med Sci       Date:  2001-12

6.  Psychologic symptoms before and after parathyroid surgery.

Authors:  B L Solomon; M Schaaf; R C Smallridge
Journal:  Am J Med       Date:  1994-02       Impact factor: 4.965

7.  Outcome study of psychological distress and nonspecific symptoms in patients with mild primary hyperparathyroidism.

Authors:  Takahiro Okamoto; Toshiko Kamo; Takao Obara
Journal:  Arch Surg       Date:  2002-07

8.  Parathyroidectomy improves concentration and retentiveness in patients with primary hyperparathyroidism.

Authors:  Gerhard Prager; Andreas Kalaschek; Klaus Kaczirek; Christian Passler; Christian Scheuba; Gernot Sonneck; Bruno Niederle
Journal:  Surgery       Date:  2002-12       Impact factor: 3.982

Review 9.  NIH conference. Diagnosis and management of asymptomatic primary hyperparathyroidism: consensus development conference statement.

Authors: 
Journal:  Ann Intern Med       Date:  1991-04-01       Impact factor: 25.391

10.  The NIH criteria for parathyroidectomy in asymptomatic primary hyperparathyroidism: are they too limited?

Authors:  Monica S Eigelberger; W Keat Cheah; Philip H G Ituarte; Leanne Streja; Quan-Yang Duh; Orlo H Clark
Journal:  Ann Surg       Date:  2004-04       Impact factor: 12.969

View more
  16 in total

1.  Evaluation of selected cognitive functions before and after surgery for primary hyperparathyroidism.

Authors:  Dominika Babińska; Marcin Barczyński; Tomasz Stefaniak; Tomasz Osęka; Anna Babińska; Dariusz Babiński; Krzysztof Sworczak; Andrzej J Lachiński; Wojciech Nowak; Zbigniew Sledziński
Journal:  Langenbecks Arch Surg       Date:  2011-12-08       Impact factor: 3.445

2.  Two cases of primary hyperparathyroidism with depressive and cognitive symptoms.

Authors:  G Paslakis; M Gilles; P Frankhauser; O Lanczik; M Deuschle; L Frölich; F H H Müller; D Kopf
Journal:  J Nutr Health Aging       Date:  2010-11       Impact factor: 4.075

3.  Neurocognitive dysfunction: a predictor of parathyroid hyperplasia.

Authors:  Daniel Repplinger; Sarah Schaefer; Herbert Chen; Rebecca S Sippel
Journal:  Surgery       Date:  2009-12       Impact factor: 3.982

Review 4.  What symptom improvement can be expected after operation for primary hyperparathyroidism?

Authors:  Nadine R Caron; Janice L Pasieka
Journal:  World J Surg       Date:  2009-11       Impact factor: 3.352

5.  Clinical presentation and management of patients with primary hyperparathyroidism of the Swiss Primary Hyperparathyroidism Cohort: a focus on neuro-behavioral and cognitive symptoms.

Authors:  A Trombetti; E R Christ; C Henzen; G Gold; M Brändle; F R Herrmann; C Torriani; F Triponez; M Kraenzlin; R Rizzoli; C Meier
Journal:  J Endocrinol Invest       Date:  2016-01-07       Impact factor: 4.256

Review 6.  Nontraditional manifestations of primary hyperparathyroidism.

Authors:  Marcella Donovan Walker; Mishaela Rubin; Shonni J Silverberg
Journal:  J Clin Densitom       Date:  2013 Jan-Mar       Impact factor: 2.617

Review 7.  Presentation of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop.

Authors:  Shonni J Silverberg; E Michael Lewiecki; Leif Mosekilde; Munro Peacock; Mishaela R Rubin
Journal:  J Clin Endocrinol Metab       Date:  2009-02       Impact factor: 5.958

8.  Age-related increases in parathyroid hormone may be antecedent to both osteoporosis and dementia.

Authors:  Eric R Braverman; Thomas J H Chen; Amanda L C Chen; Vanessa Arcuri; Mallory M Kerner; Anish Bajaj; Javier Carbajal; Dasha Braverman; B William Downs; Kenneth Blum
Journal:  BMC Endocr Disord       Date:  2009-10-13       Impact factor: 2.763

9.  Neuropsychological features in primary hyperparathyroidism: a prospective study.

Authors:  Marcella D Walker; Donald J McMahon; William B Inabnet; Ronald M Lazar; Ijeoma Brown; Susan Vardy; Felicia Cosman; Shonni J Silverberg
Journal:  J Clin Endocrinol Metab       Date:  2009-03-31       Impact factor: 5.958

10.  Association of parathyroid hormone with 20-year cognitive decline: The ARIC study.

Authors:  Samuel M Kim; Di Zhao; Andrea L C Schneider; Sai Krishna Korada; Pamela L Lutsey; Eliseo Guallar; Alvaro Alonso; B Gwen Windham; Rebecca F Gottesman; Erin D Michos
Journal:  Neurology       Date:  2017-08-02       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.